Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

A Phase 2, Double-Blind, Randomized, Placebo and Active-Controlled Dose-Finding Study to Assess the Efficacy, Safety and Tolerability of Multiple Oral Doses of ASP1941 in Subjects with Type 2 Diabetes Mellitus
ipragliflozin
1941-CL-0004
NCT01071850
Diabetes Mellitus, Type 2
Phase 2
 
August 2015

Powered by ideaPoint, Inc.